Shanghai Fosun Pharmaceutical has secured a green light from both the China Securities Regulatory Commission and the authorities in Hong Kong for its long-awaited initial public offering on HKEx, which means that launch could start soon.
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- Asia Australia Brazil Business trusts Canada China Cornerstones Corporate governance De-listing Depositary receipts Dual listings Events Fees France Hong Kong Independent advisers India Interviews IPO pipeline Italy Japan Liquidity Listing by introduction Malaysia Market conditions NYSE Over-allotment options Pitches Primary offerings Privatization Prospectuses REITs Retail offers Secondary listings Secondary offerings Singapore South Korea Spin-offs Sponsors Switzerland Trading volume UK US Valuation Yuan securities

